[On-demand Webinar] Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare?

Watch on-demand: Will Covid-19 Accelerate the Next Wave of Adoption of Next-Generation Sequencing (NGS) in Healthcare?

Sequencing-based diagnostic testing has been on the uptrend, with the adoption of next-generation sequencing (NGS) testing in oncology, genetics and prenatal screening – areas where the vast majority is done – continuing to grow strongly.

Now, sequencing looks set to become even more integral in the healthcare system with the Covid-19 pandemic highlighting the power of sequencing-based diagnostic testing in global efforts to combat the spread of the infectious disease; and its importance in supporting recovery efforts. In the evolving market for diagnostics, how and where can sequencing companies and other IVD players find growth opportunities.

Date of recording: Wednesday, 23 September 2020
Duration: 1 hour with live Q&A


Chee Hew  
Director, data analytics & consulting, Clearstate

Kathrin Franke
Managing director, Clearstate 

Watch the recording and gain answers to the questions:

  • How has Covid-19 impacted EIU Healthcare’s forecast data on the global NGS market (with focus in Asia-Pacific and Europe markets) – for sequencing instruments and in test areas such as oncology, NIPT and infectious diseases? When can growth recovery be expected?
  • What is the longer term outlook on sequencing-based testing opportunities in these areas?
  • How is increasing competition posed by rising domestic players in countries such as China and new commercial models shaping the market?
  • How will the market for NGS testing evolve as technology development is expected to reduce the operational cost of NGS testing for smaller volume labs?
  • How will the growing adoption of NGS impact the use of other competing diagnostic technologies in areas such as molecular diagnostics and tissue diagnostics?

Register to watch the on-demand recording

Clearstate newsletter

Sign up to Clearstate's newsletter for insights into key market data, trends and developments across IVD and Surgical segments from our specialists and analysts.